Integrin αvβ3-targeted radionuclide therapy with 177Lu-AB-3PRGD2 in multiple advanced metastatic solid tumors: A prospective, single-arm, single-center, investigator-initiated clinical trial.
用户GpuT45j1J7lQ
1小时前
10
20
已关闭
DOI: 10.1200/jco.2026.44.16_suppl.3009
文献链接: https://ascopubs.org/doi/10.1200/JCO.2026.44.16_suppl.3009
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Hao Fu; Jingxiong Huang; Wei Guo; Liang Zhao; Hua Wu; Fan Wang; Haojun Chen

